NDC product
Rynex DM
NDC 0485-0204 · Edwards Pharmaceuticals, Inc
Key facts
| Product NDC | 0485-0204 |
|---|---|
| Proprietary name | Rynex |
| Nonproprietary name | Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
| Substances | PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Edwards Pharmaceuticals, Inc |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Mar 14, 2011 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: